Key result
This literature review aims to determine if a relationship exists between recurrent hypoglycemia and adverse neurovascular events in patients with diabetes mellitus.
Why the study?
Does recurrent hypoglycemia increase the risk of adverse neurovascular events in patients with diabetes mellitus?
Does recurrent hypoglycemia increase the risk of adverse neurovascular events in patients with diabetes mellitus?
This review aims to explore the relationship between recurrent hypoglycemia and the risk of adverse neurovascular events such as stroke in diabetic patients.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for neurovascular risk with recurrent hypoglycemia in diabetes; leaves association and practice implications open.
In the treatment of both type 1 and type 2 diabetes mellitus, maintaining a euglycemic state represents one of the key challenges. Improper dosing and administration of glucose-lowering drugs is associated with an increased risk of recurrent hypoglycemia episodes. In addition, the risk of adverse cardiovascular events in diabetic patients, particularly myocardial infarctions and strokes, is well established. Current research indicates a potential link between the baseline risk of cardio/cerebrovascular events in diabetic patients and exposure to hypoglycemia. In this review of the literature, we aim to determine if a relationship exists between recurrent hypoglycemia and adverse neurovascular events.
No takes yet. Share an insight, caveat, or question.
Smith et al. (2018) conducted a review in Type 1 and type 2 diabetes mellitus. Hypoglycemia was evaluated on Adverse neurovascular events. This literature review aims to determine if a relationship exists between recurrent hypoglycemia and adverse neurovascular events in patients with diabetes mellitus.
Synapse has enriched 10 related papers. Consider them for comparative context: